Zobrazeno 1 - 6
of 6
pro vyhledávání: '"L. Rabey"'
Publikováno v:
Physiotherapy. 107:e188
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::999bf744cabefc3f915d1d1c9213d53f
https://doi.org/10.1016/j.physio.2020.03.275
https://doi.org/10.1016/j.physio.2020.03.275
Publikováno v:
Journal of Pharmacy Practice. 27:31-39
Objectives: This study evaluated whether particular diabetes mellitus (DM), hyperlipidemia, or hypertension pharmacotherapy was associated with improved renal cell carcinoma (RCC) outcomes in diabetics with emergent RCC. Methods: All DM cases newly d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74140b89911c275e499459dc1ef77599
https://doi.org/10.1177/0897190013501698
https://doi.org/10.1177/0897190013501698
Autor:
Hamed Radpasand, Zachary A.P. Wintrob, Asante Barima, Eva Surmacz, Silviu L. Faitar, Alice C. Ceacareanu, Mohamed H. Elmeshad, Zahra Fayazi, Lazlo Otvos, Kristina A. Chmiel, Jonathan L. Rabey
Publikováno v:
The FASEB Journal. 27
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::888951a896f80e782b2cf81c20710ccc
https://doi.org/10.1096/fasebj.27.1_supplement.1123.13
https://doi.org/10.1096/fasebj.27.1_supplement.1123.13
Autor:
L. A. Ford, Huan-Ching Chuang, Jonathan L. Rabey, Thang Q. Bui, Dustyn S. Miller, Alice C. Ceacareanu, Zachary A.P. Wintrob, Meir Wetzler, Michelle E. Amsler
Publikováno v:
Cancer Research. 73:LB-17
Background: Association of non-secretagogues, metformin and thiazolidindiones, with lower cancer risk and improved survival has led to numerous clinical studies exploring their benefit as adjuvants in cancer chemotherapy. However, the most utilized,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2375f933d733e2ae80c7ac7638394d80
https://doi.org/10.1158/1538-7445.am2013-lb-17
https://doi.org/10.1158/1538-7445.am2013-lb-17
Autor:
Kristopher Attwood, Thomas Schwaab, Jonathan L. Rabey, Alice C. Ceacareanu, Charlene Lee, Nicolas Batty, John M.L. Ebos, Dustyn S. Miller, Saby George, Roberto Pili, Ahmad Ahmad, Ellen Kossoff
Publikováno v:
Journal of Clinical Oncology. 30:e15042-e15042
e15042 Background: In metastatic renal cell carcinoma (mRCC), there is a need for predictive indicators for treatment duration (TD) of sunitinib. Our study evaluates parameters that may be associated with TD of sunitinib. Methods: From 01/2007-12/201
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed0ca0051491d6145a60fe2aade0e58e
https://doi.org/10.1200/jco.2012.30.15_suppl.e15042
https://doi.org/10.1200/jco.2012.30.15_suppl.e15042
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.